The Future of Atopic Dermatitis Treatment: The Latest Patient Outcomes

This promotional content is funded by Leo Pharma and is intended for healthcare professionals only.

The medicinal product mentioned in this infographic, Adtralza▼ (tralokinumab), is subject to additional monitoring